VTGN: Kapitalisasi pasar Vistagen Therapeutics

Vistagen Therapeutics (VTGN) focuses on developing innovative anxiety-relief sprays, preparing its US distribution infrastructure and attracting global partners. The business faces intense pressure from corporate behemoths and affordable alternatives. Risks are linked to past testing failures and the need for new capital, with a market capitalization of 0.01. This daily price chart is provided below for analytical convenience.

VTGN VistaGen Therapeutics, Inc.: Kapitalisasi pasar ing interval 04.07.2022 - 22.10.2026

VTGN (vistagen.com): rincian analitis lan laporan miturut indikator

Ringkesan indikator lan parameter pambiji Vistagen Therapeutics (VTGN):

Kutipan saham Vistagen|VTGN - Rega prakiraan analis|Kapitalisasi pasar VTGN

Analisis fundamental perusahaan:VTGN (VistaGen Therapeutics Inc)

Sampel barang VistaGen Therapeutics, Inc.

Investors assess the operational strength of assets through the total market capitalization of a company's shares. For Vistagen Therapeutics (VTGN), this parameter reflects market optimism regarding the success of its nasal spray. The daily price action of the issuer's market valuation allows for the real-time assessment of shifting participant sentiment and inflationary pressure. Rising capitalization confirms the brand's reputational surge following successful clinical trials. The current valuation demonstrates a high degree of confidence from the professional community in the business.

Pesaing wigati

Biogen - Biji pasar|Nilai pasar NBIX (Neurocrine)|Regencell - Kapitalisasi pasar|Kapitalisasi pasar Axsome Corp (AXSM)|ACADIA Pharmaceuticals (ACAD) - Nilai pasar|Kapitalisasi pasar XENE|Nilai pasar Viking Therapeutics, Inc.|Kapitalisasi pasar SUPN (Supernus Pharmaceuticals, Inc.)|Kapitalisasi pasar CPRX|DNLI - Nilai pasar|Harmony Biosciences - Biji pasar|Kapitalisasi pasar biohavenpharma.com BHVN|AMLX - Nilai pasar|Nilai pasar TRVI (Trevi Therapeutics Inc)|Praxis Medicines (PRAX) - Nilai pasar|Nilai pasar Anavex Life Sciences Corp (AVXL)|Biji pasar CBLL|Nilai pasar PRTA|Kapitalisasi pasar ALEC|Kapitalisasi pasar Annexon Biosciences|Nilai pasar Omeros OMER|Kapitalisasi pasar Neurogene Therapeutics (NGNE)|ACIU: Biji pasar|voyagertherapeutics.com - Nilai pasar|NMRA: Kapitalisasi pasar|Scilex Holding (SCLX) - Kapitalisasi pasar|TVGN (Tevogen Bio Holdings, Inc.) - Kapitalisasi pasar|ACOG - Kapitalisasi pasar|Kapitalisasi pasar CGTX|IKT - Nilai pasar|Nilai pasar Cassava Sciences SAVA|ASRT: Kapitalisasi pasar|COYA: Biji pasar|Nilai pasar OVID (Ovid Therapeutics Inc.)|ABOS (Acumen Pharmaceuticals) - Biji pasar|CRVO: Nilai pasar|ATHE (Alterity Therapeutics Ltd.) - Kapitalisasi pasar|CLNN: Nilai pasar|Kapitalisasi pasar PEPG|JUNS - Nilai pasar|Nilai pasar Relmada Therapeutics RLMD|Nilai pasar ANVS|Grace Tx - Kapitalisasi pasar|AIFF - Kapitalisasi pasar|anewmeds.com (KLTO) - Nilai pasar|Biji pasar NRSN (NeuroSense Therapeutics Ltd.)|RVPH (Reviva Pharmaceuticals) - Kapitalisasi pasar|Nilai pasar MetaVia, Inc. MTVA|Biji pasar NRXS (NeurAxis)|Kapitalisasi pasar heliusmedical.com (HSDT)|Passage Bio - Biji pasar|Nilai pasar NEUP (Neuphoria Therapeutics, Inc.)|Minerva Neurosciences - Kapitalisasi pasar|Kapitalisasi pasar athira.com ATHA|ADXN: Kapitalisasi pasar|Biji pasar Alzamend Neuro|Nilai pasar Cyclerion Therapeutics Inc.|Protagenic (PTIX) - Kapitalisasi pasar|Biji pasar KTTA (Pasithea Therapeutics)|Nilai pasar CRGT (cortigent.com)|Avenue Therapeutics, Inc. - Biji pasar|Nilai pasar BCLI (Brainstorm Cell Therapeutics Inc.)|Cara Therapeutics, Inc - Kapitalisasi pasar|Kapitalisasi pasar Chromocell (CHRO)|eliemtx.com (ELYM) - Nilai pasar|Kapitalisasi pasar ITCI|Nilai pasar Longboard Pharmaceuticals, Inc.|Kapitalisasi pasar MRNS (Marinus Pharmaceuticals Inc)|Kapitalisasi pasar NKGN|NRBO - Nilai pasar|Sage Therapeutics, Inc. - Biji pasar|Kapitalisasi pasar synaptogen.com SNPX|TRVN - Nilai pasar|Nilai pasar VIGL (Vigil Neuroscience)|Anew Medical, Inc. (WENA) - Nilai pasar|Nilai pasar Cerevel Corp (CERE)